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Abstract
African swine fever (ASF) is caused by a large and highly pathogenic DNA virus, African swine fever virus (ASFV), which
provokes severe economic losses and expansion threats. Presently, no specific protection or vaccine against ASF is available,
despite the high hazard that the continued occurrence of the disease in sub-Saharan Africa, the recent outbreak in the
Caucasus in 2007, and the potential dissemination to neighboring countries, represents. Although virus entry is a
remarkable target for the development of protection tools, knowledge of the ASFV entry mechanism is still very limited.
Whereas early studies have proposed that the virus enters cells through receptor-mediated endocytosis, the specific
mechanism used by ASFV remains uncertain. Here we used the ASFV virulent isolate Ba71, adapted to grow in Vero cells
(Ba71V), and the virulent strain E70 to demonstrate that entry and internalization of ASFV includes most of the features of
macropinocytosis. By a combination of optical and electron microscopy, we show that the virus causes cytoplasm
membrane perturbation, blebbing and ruffles. We have also found that internalization of the virions depends on actin
reorganization, activity of Na
+/H
+ exchangers, and signaling events typical of the macropinocytic mechanism of endocytosis.
The entry of virus into cells appears to directly stimulate dextran uptake, actin polarization and EGFR, PI3K-Akt, Pak1 and
Rac1 activation. Inhibition of these key regulators of macropinocytosis, as well as treatment with the drug EIPA, results in a
considerable decrease in ASFV entry and infection. In conclusion, this study identifies for the first time the whole pathway
for ASFV entry, including the key cellular factors required for the uptake of the virus and the cell signaling involved.
Citation: Sa ´nchez EG, Quintas A, Pe ´rez-Nu ´n ˜ez D, Nogal M, Barroso S, et al. (2012) African Swine Fever Virus Uses Macropinocytosis to Enter Host Cells. PLoS
Pathog 8(6): e1002754. doi:10.1371/journal.ppat.1002754
Editor: Bala Chandran, Rosalind Franklin University of Medicine and Science, United States of America
Received December 28, 2012; Accepted April 30, 2012; Published June 14, 2012
Copyright:  2012 Sa ´nchez et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Spanish Ministerio de Ciencia e Innovation (BFU2007-63110/BFU2010-17794), from the European
Community’s Seventh Framework Programme (FP7/2007-2013)), under grant agreement KBBE-211691- ASFRISK, and by an institutional grant from the Fundacio ´n
Ramo ´n Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: yrevilla@cbm.uam.es
Introduction
ASFV is a 200 nm large DNA virus that infects different species of
swine, causing acute and often fatal disease [1–3]. Infection by ASFV is
characterized by the absence of a neutralizing immune response, which
has so far hampered the development of a conventional vaccine. A
strong hazard of ASFV dissemination through EU countries from
Caucasian areas has recently emerged, thus making progress of
knowledge and tools for protection against this virus urgent.
Analysis of the complete DNA sequence of the 170-kb genome
of the Ba71V isolate, adapted to grow in Vero cells, has revealed
the existence of 151 genes, a number of enzymes with functions
related to DNA replication, gene transcription and protein
modifications, as well as several genes able to modulate virus-
host interaction [4–12].
ASFV replicates within the host cell cytosol, although a nuclear
step has been reported [13,14]. Discrete cytoplasmic areas are
reorganized into viral replication sites, known as factories, during
the productive virus cycle. Regarding this, we have recently
described ASFV replication as fully dependent on the cellular
translational machinery since it is used by the virus to synthesize
viral proteins. Thus, during infection, factors belonging to the
eukaryotic translational initiation complex eIF4F are phosphory-
lated, and then redistributed to the periphery of the ASFV factory.
Furthermore, ASFV late mRNAs, ribosomes and mitochondrial
network were also located in these areas [15]. Such phosphory-
lation events and redistribution movements suggest, first, a
reorganization of the actin skeleton induced by ASFV, and
second, virus-dependent kinases activation mechanisms. Several
other critical steps of the infection, probably including virus entry
and trafficking, might be also regulated by phosphorylation of key
molecules targeted by the virus.
As the first step of replication, entry into the host cell is a
prominent target for impairing ASFV infection and for potential
vaccine development. Endocytosis is a major pathway of pathogen
uptake into eukaryotic cells [16]. Clathrin-mediated endocytosis is
one of the best studied receptor-dependent pathways, character-
ized by the formation of clathrin coated pits of 85–110 nm in
diameter that bud into the cytoplasm to form clathrin-coated
vesicles. Relatively low size viruses, as Vesicular stomatitis virus,
Influenza virus, and Semliki forest virus all enter their host cells
using this mechanism [17–19]. On the other hand, the caveolae-
mediated pathway is dependent on small vesicles termed caveolae
(50–80 nm) enriched in caveolin, cholesterol, and sphingolipid. It
has been implicated in the entry of other small viruses such as
Simian virus 40 [20].
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used by several viruses to enter host cells. It is defined as an actin-
dependent endocytic process associated with a vigorous plasma
membrane activity in the form of ruffles or blebs induced by
activation of kinases and Rho GTPases. This pathway involves
receptor- independent internalization of fluid or solutes into large
uncoated vesicles sized between 0.5–10 mm called macropino-
somes [21,22]. In recent years, it has been reported that
macropinocytosis is responsible for virus entry of Vaccinia virus
(VV) [23,24], Coxsackievirus [25], Adenovirus-3 [26], Herpes
simplex virus [27–29], and is required for other viruses to promote
viral internalization after entry by some different endocytic
mechanism [30–32].
Regarding ASFV entry, preliminary studies were reported
many years ago by our lab describing this process as temperature,
energy, cholesterol and low pH-dependent, and also showing that
ASFV strain Ba71V enters Vero cells by receptor-mediated
endocytosis [33–37]. However, the cellular molecules involved and
the precise mechanisms for ASFV entry remain largely unknown.
A recent paper [38] reported that ASFV uses dynamin and
clathrin-dependent endocytosis to infect cells. However, it is
noteworthy that this work employed the expression of ASFV early
proteins as readout of virus entry, which is not equivalent to virus
uptake, since several post-entry events could be involved in virus
early protein expression. Hence, explanation of several controver-
sial points, such as the larger size of ASFV (200 nm) compared to
the smaller size (50–80 nm) of clathrin coated pits, or the existence
of several other possible roles for dynamin in addition to virus
entry [39], are not discussed in that work.
In the present work we have characterized the mechanisms of
entry of ASFV-Ba71V and ASFV-E70 strains either in Vero or
swine macrophages, as representative models for ASFV infection.
By means of a combination of pharmacological inhibitors, specific
dominant-negatives and confocal and electron microscopy, we
show that ASFV is taken up predominantly by macropinocytosis.
Therefore, we provide evidence, for the first time, that the ASFV
entry requires sodium/proton exchanger (Na
+/H
+), activation of
EGFR and PI3K, phosphorylation of Pak1 kinases together with
activation of Rho-GTPase Rac1 and relies on actin-dependent
blebbing/ruffling formation, all events fully linked with macro-
pinocytosis activation.
Materials and Methods
Cell culture, viruses and infections
Vero (African green monkey kidney) cells were obtained from
the American Type Culture Collection (ATCC) and grown in
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented
with 5% fetal bovine serum (Invitrogen Life Technologies). IPAM
cells (porcine macrophage-derived cell lines) were kindly provided
by Dr. Parkhouse (Fundac ¸ao Calouste Gulbenkian - Instituto
Gulbenkian de Cie ˆncia, Oeiras, Portugal) and grown in RPMI
1640 medium supplemented with 10% fetal bovine serum. Cells
were grown at 37uC under a 7% CO2 atmosphere saturated with
water vapour in a culture medium supplemented with 2 mM L-
glutamine, 100 U/ml gentamicin and nonessential amino acids.
The Vero-adapted ASFV strain Ba71V and isolate E70 were
propagated and titrated by plaque assay on Vero cells, as
described previously [40,41]. In brief, subconfluent Vero cells
were cultivated in roller bottles and infected with ASFV at a
multiplicity of infection (MOI) of 0.5 in DMEM 2% fetal bovine
serum. After 72 h post infection the cells were recovered and
centrifuged at 3000 rpm for 15 min and the cellular pellet was
discarded. The supernatant containing viruses was clarified at
14000 rpm for 6 h at 4uC and the purified infectious virus was
resuspended in medium and stored at 280uC. Vero cells were
infected with Ba71V isolate and IPAM cells with E70 or Ba71V as
indicated. The MOI used ranged from 1 to 3000 pfu/cell, as
explained.
Viral adsorption to cells was performed at 4uC (synchronic
infection) or at 37uC (asynchronic infection) during 90 min (or
60 min when indicated), followed by one wash with cold PBS, and
a shift to 37uC to allow the infection until indicated times.
Pharmacological inhibitors and antibodies
Pharmacological inhibitors were prepared either in water or
DMSO following the manufacturer’s recommendation and used at
the indicated concentration. 5- ethylisopropyl amiloride (EIPA),
Cytochalasin D (Cyto D), Genistein, IPA-3, Chlorpromazine
(CPZ), Dynasore (Dyn) and Nocodazole were purchased from
Sigma. 6Blebbistatin, EGFR inhibitor (324674) and Rac1
inhibitor (Rac1 Inh, NSC23766) was purchased from Calbiochem,
and LY294002 (LY) from Echelon.
Specific antibodies against Akt, phospho-Akt (Thr308), phos-
pho-Akt (Ser473) and PI3K p85 were purchased from Cell
Signaling Technology; anti-Pak1, anti- phospho-Pak1 (Thr423),
anti-Rock1 and anti-b-actin from Santa Cruz Biotechnology, Inc.
Rac1 was detected with a monoclonal antibody from Millipore,
kindly provided by Dr. C. Murga (CBMSO, Madrid, Spain).
Monoclonal anti-p72 (17LD3) [42] was a kind gift from Ingenasa
and polyclonal antibodies risen against p72, p32 and most of the
ASFV structural proteins (anti-ASFV) were generated in our
laboratory. Alexa Fluor 594-WGA, TRITC- phalloidin, Alexa
Fluor 488-phalloidin, Topro3, anti-mouse Alexa Fluor-488, anti-
goat Alexa Fluor-555 and anti-mouse Alexa Fluor-555 were
purchased from Invitrogen, and anti-rabbit, anti-mouse and anti-
goat immunoglobulin G coupled to peroxidase from Amersham
Biosciences.
Plasmids construct
GFP-tagged versions of wild type forms of actin (pEGFP-actin)
and Rac1 (pEGFP-Rac1) were kindly provided by Dr. J. Mercer
(ETH Zurich, Institute of Biochemistry, Zurich, Switzerland) and
Author Summary
ASFV is a highly pathogenic zoonotic virus, which can
cause severe economic losses and bioterrorism threats. No
vaccine against ASFV is available so far. A strong hazard of
ASFV dissemination through EU countries from Caucasian
areas has recently emerged, thus making urgent to acquire
knowledge and tools for protection against this virus.
Despite that, our understanding of how ASFV enters host
cells is very limited. A thorough understanding of this
process would enable to design targeted antiviral thera-
pies and vaccine development. The present study clearly
defines key steps of ASFV cellular uptake, as well as the
host factors responsible for permitting virus entry into
cells. Our results indicate that the primary mechanism of
ASFV uptake is a macropinocytosis-like process, that
involves cellular membrane perturbation, actin polariza-
tion, activity of Na
+/H
+ membrane channels, and signaling
proceedings typical of the macropinocytic mechanism of
endocytosis, such as Rac1-Pak1 pathways, PI3K and
tyrosine-kinases activation. These findings help under-
standing how ASFV infects cells and suggest that
disturbance of macropinocytosis may be useful in the
impairment of infection and vaccine development.
ASFV Entry by Macropinocytosis
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R. Madrid (CBMSO, Madrid, Spain). GFP-tagged versions of
WT, AID, and T423E of Pak1 constructs were a gentle gift from
Dr. J. Chernoff (Fox Chase Cancer Center, Philadelphia, PA,
USA) and pEGFP-C2 was purchased from Invitrogen.
ASFV uptake and infection assays
To analyze ASFV uptake, Vero cells were pretreated with the
pharmacological inhibitors listed above at 37uC for 60 min in
serum free medium. Ba71V synchronic infection was carried out
at a MOI of 10 pfu/cell in the presence of the drugs. After
binding, cells were washed once with cold PBS, followed by the
addition of containing drug medium, and infection was allowed to
proceed for 60 min at 37uC. After infection, cells were fixed and
prepared either for Fluorescence Activating Cell Sorting (FACS)
or Confocal Laser Scanning Microscopy (CLSM) analysis.
The specific effect of the drugs on virus entry and post entry steps
was analyzed by incubation of the cells either 60 min before virus
addition or 60 min after virus addition, and viral infection was
allowedinthe presenceofthedrugs at 37uC,in each case.Ba71V or
E70 asynchronic infection was carried out for 16 or 48 h at a MOI
of 1 pfu/cell or at a MOI of 5 pfu/cell to analyze viral proteins by
Western blot or number of infected cells by CLSM, respectively.
To analyze Akt phosphorylation upon ASFV infection, Vero
cells were infected at a MOI of 10 pfu/cell and viral adsorption
was allowed for 60 min at 37uC. Actin distribution analysis was
performed at different times post infection since virus addition at
37uC at MOI 50. Rac1 distribution and Pak1 phosphorylation was
measured after synchronic infection at a MOI of 10 pfu/cell. At
the indicated times, cells were prepared for Western blot or CLSM
analysis.
Viral production assays
Vero cells were pretreated with DMSO or pharmacological
inhibitors for 60 min at 37uC. The asynchronic infection was
carried out at a MOI of 1 pfu/cell for 48 h in the presence of the
inhibitors and the supernatant was recovered. The number of
productive viral particles was titrated by plaque assays on Vero
cells as described in [41].
Field Emission Scanning Electron Microscopy (FESEM)
Cells were grown on glass coverslips, serum starved for 24 h,
infected synchronously (MOI 50) and at the indicated times post
infection, fixed in 2.5% glutaraldehyde and 4% paraformaldehyde
in 0.1 M phosphate buffer (pH 7.4) for 3 h at 4uC. They were
washed three times in phosphate buffer, postfixed in 2% OsO4/
water at RT for 60 min, washed in water, dehydrated in acetone,
critical point dried for 2 h and coated with graphite-gold in a
sputter coater. The samples were analyzed with a JSM-6335-F
(JEOL) Field Emission SEM (Electron Microscopy National
Center, UCM; Madrid, Spain).
Transmission Electron Microscopy (TEM)
Vero cells were serum starved 24 h and virus binding was
allowed for 90 min at 4uC with Ba71V (MOI 3000). Cells were
fixed with 2% glutaraldehyde and 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4) for 3 h at 4uC. Sections of infected cells
were prepared as described [43] and analyzed in a JEOL 100B
electron microscope.
Phase Contrast Microscopy and Nomarski
In order to study real-time live imaging of ruffles formation
induced by ASFV infection, Vero cells were serum starved for
24 h and virus binding was allowed for 90 min at 4uC at MOI
100. After binding, cells were washed with cold PBS and images
were collected for 30 min with an Orca R2 digital camera
(Hamamatsu) on a wide-field microscope (LeicaDMI6000B, Leica
Microsystems) with controlled environmental chamber (tempera-
ture 37uC and 5% CO2 humidified atmosphere). Images were
captured with LAS AF version 2.6.0 software (Leica Microsystems)
at a resolution of 134461024 pixels using a 206, 0.40 NA
objective with a 1.66 magnification-changer, and analyzed with
Image J software.
To analyze blebs formation, IPAM cells were infected
synchronously (MOI 50) and at different times post infection,
fixed with paraformaldehyde 4% for 20 min. Images were taken
with a ccd monochrome camera (Hamamatsu) on a invert
microscope (Axiovert200, Zeiss) using a 636 objective and
analyzed with Image J program.
Fluorescence Activated Cell Sorting (FACS)
Mock-infected or infected cells in the presence of pharmaco-
logical inhibitors were detached with trypsin-EDTA after 60 min
post infection (mpi), fixed with 2% paraformaldehyde for 30 min
at 4uC and then permeabilized with PBS-Staining buffer (PBS 16,
0.01% sodium azide, 0.5% BSA) 0.2% saponin for 15 min at RT.
Detection of infected cells was performed by incubation with an
anti-p72 monoclonal antibody (17LD3) (diluted 1:100 in PBS-
Staining buffer 0.2% saponin) for 20 min at 4uC, followed by
incubation with an anti-mouse Alexa Fluor-488 (diluted 1:500 in
PBS-Staining buffer, 0.2% saponin) in the same conditions.
Finally, 2610
4 cells were analyzed in a FACSCalibur flow
cytometer (BD Science) to determine the percentage of infected
cells. All FACS analyses were performed at least in triplicate and
displayed as the average percentage of infected cells relative to
control infection in the absence of a pharmacological inhibitor.
Error bars represent the standard deviation between experiments.
Confocal Laser Scanning Microscopy (CLSM)
Cells were grown on glass coverslips and, at indicated times post
infection, were fixed with 4% paraformaldehyde for 20 min and
permeabilized with PBS-0.2% Triton X-100 for 30 min at RT.
Viral particles or infected cells were stained with an anti-p72
monoclonal antibody (17LD3) (diluted 1:250 in PBS-5% BSA) for
60 min at RT, followed by incubation with an anti-mouse Alexa
Fluor-488 or an anti-mouse Alexa Fluor-555 for the same time.
Alexa Fluor-488 phalloidin (dilution 1:100) or TRICT- phalloidin
and Topro3 (dilution 1:500) were used to stain actin filaments and
nuclei of cell, respectively. Goat anti-Rock1 was used at a dilution
1:50.
To analyze the virus binding to the cellular membrane, the viral
adsorption was allowed for 90 min at 4uC (MOI 10) and after
60 min from virus addition cells were incubated with Alexa Fluor
594-WGA for 30 min. Cells were washed twice with cold PBS-
0.1% BSA Buffer and incubated with anti-p72 monoclonal
antibody (17LD3) and Alexa Fluor-488 for 60 min at 4uC. Finally,
cells were fixed with 4% paraformaldehyde at RT for 20 min.
Samples were analyzed by CLSM (Zeiss LSM510) with a 636
oil immersion objective. To investigate ASFV uptake as well as
actin, Rock1 and Rac1 distribution, Z-slices per image were
collected and displayed as maximum z-projection of vertical slices
(x–z plane) and/or maximum z-projection of horizontal slices (x–y
plane). For presentation of images in the manuscript, LSM images
were imported into Image J software for brightness and contrast
enhancements. In all instances one image is representative of three
independent experiments.
ASFV Entry by Macropinocytosis
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automatically by a Macro algorithm from Image J program
(developed by CBMSO Confocal Microscopy Service, Spain) in
which Intermode threshold was used to count the number of virus
inside the cells.
Fluid phase uptake assays
Vero cells were serum starved for 24 h and pretreated with
DMSO or EIPA. After 60 min at 37uC the cells were synchro-
nously infected (MOI 10) or treated with PMA (200 nM) at 37uC
for 30 min. Fifteen min prior to harvesting or fixation, cells were
incubated with 0.5 mg/ml 10 KDa 647-dextran or 3 KDa Texas
Red-dextran (Invitrogen) at 37uC. Dextran uptake was stopped by
placing the cells on ice and washing three times with cold PBS and
once with low pH buffer (0.1 M sodium acetate, 0.05 M NaCl,
pH 5.5) for 10 min. Then, the cells were prepared for FACS or
CLSM analysis. In FACS experiments dextran uptake was
displayed as fluorescence mean of three independent experiments.
Error bars represent the standard deviation between experiments.
Cells without wash acid buffer were added as an experiment
control.
Western blot analysis
At indicated times post infection, cells were washed with PBS
and lysed in RIPA modified buffer (50 mM Tris-HCl pH 7.5, 1%
NP40, 0.25% Na-deoxycolate, 150 mM NaCl, 1 mM EDTA)
supplemented with protease and phosphatase inhibitor cocktail
tablets (Roche). The protein concentration was determined by a
Pierce BCA Protein Assay kit based on the bicinchoninic acid
spectrophotometric method (Thermo Scientific). Cell lysates (15–
50 mg of protein) were fractionated by SDS-PAGE and electro-
phoretically transferred to an Immobilon extra membrane
(Amersham) and the separated proteins reacted with specific
primary antibodies. The antibodies used were the following:
polyclonal anti-p72 (dilution 1:2000), anti-p32 (dilution 1:1000),
anti-ASFV (dilution 1:3000); anti-Akt, anti-phospho Akt (Thr308),
anti-phospho Akt (Ser473), anti-Pak1 and anti-phospho Pak1
(Thr423) (dilution 1:500); anti-b-actin and anti-Rac1 (dilution
1:1000). Membranes were exposed to horseradish peroxidase-
conjugated secondary antibodies (dilution 1:5000) followed by
chemiluminescence (ECL, Amersham Biosciences) detection by
autoradiography. In all instances the figures are representative of
three independent experiments.
PI3K activation assay
Vero cells were serum starved for 24 hours and treated with
DMSO or LY294002 for 60 min at 37uC in serum free medium.
Asynchronic infection (viral adsorption for 60 min) was carried out
at a MOI of 10 pfu/cell in the presence of the drug at 37uC until
indicated times. PI3K subunit p85 was immunoprecipitated from
lysed cells and PI3-kinase activity was measured as PI(3,4,5)P3
production by ELISA activation kit, following the manufacturer’s
recommendations (Kit#1001s Echelon).
Rac1 activation assays
Vero cells were serum starved for 24 hours before synchronic
infection at a MOI of 10 pfu/cell. The cells were washed once
with cold PBS, shifted to 37uC and harvested at the indicated
times post infection. Rac1 activation was measured with a G-LISA
activation kit (Kit #BK128 Cytoskeleton, Inc.) and by immuno-
blotting after a Pak1-PBD-Agarose Beads (Upstate) pull down step
as described following the manufacturer’s recommendations.
Bound Rac1-GTP was detected by incubation with an anti-Rac1
specific antibody followed by a secondary antibody conjugated to
HRP and a detection reagent. The signal was read by measuring
absorbance at 490 nm using a microplate reader and by
autoradiography.
Acid-mediated endocytosis by-pass assay
To check if the EIPA inhibitor was specifically blocking virus
entry and not a down-stream process such as early gene
expression, we induced the fusion of the viral membrane with
the plasma membrane (PM) by lowering the pH of the medium
[23]. The cells were pretreated with EIPA for 60 min at 37uCi n
serum free medium. Viral adsorption was allowed at MOI 1 for
90 min at 37uC in neutral (7.4) or acid (5.0) pH. Cells were washed
once with cold PBS and infection was allowed to proceed for 16 h
at 37uC in the presence of the inhibitor in neutral pH. Samples
were prepared for Western blot analysis.
Transfection assays
Vero cells were transfected with 1 mg of specific expression
plasmids per 10
6 cells using the LipofectAMINE Plus Reagent
(Invitrogen) according to the manufacturer’s instructions and
mixing in Opti-MEM (Invitrogen) in a 6-well plate. Cells were
incubated at 37uC for 4 h in serum free medium, washed and
incubated at 37uC. After 16 or 24 h post transfection the cells were
infected at indicated MOI and either lysated and analyzed by
Western blot, or fixed and prepared for CLSM analysis.
P72 protein detection in purified viruses
In order to analyze the localization of p72 in the viral particle,
we carried out an experimental procedure as described in [44]. In
brief, purified virus was treated with different buffers (Buffer 1 and
2) for 30 min at RT and the separate samples were centrifugated
over sucrose (20% in PBS) cushion in a Beckman Airfuge at 24
p.s.i. for 15 min. The supernatant (SP) and pellet (P) were
analyzed by Western blot by incubation with anti-p72 monoclonal
antibody (17LD3). Buffer 1: 10 mM Tris pH 8, 0.65 M NaCl,
0.5% octil b- D- Glucopyranoside (Sigma); Buffer 2: 10 mM Tris
pH 8, 0.65 M NaCl, 0.2% octil b- D- Glucopyranoside (Sigma)
and 0.1% Dithiothreitol (DTT).
Toxicity analysis by Trypan Blue
To check cell viability after treatment with inhibitors cells were
dyed with Trypan Blue and dead cells were counted in
hemocytometer as blue cells.
Densitometry analysis
After Western Blot analysis, bands developed by ECL
chemiluminescence were digitalized by scanning and quantified
with Fujifilm Multi Gauge V3.0 software. Data were normalized
after subtracting background values and calculated as factors by
their ratio against the highest or lowest positive value obtained. All
quantifications represent the mean of three independent experi-
ments.
Accession numbers
ASFV proteins in Swiss Prot database: p72:
MCP_ASFB7; p32: P30_ASFB7; p17: P17_ASFB7; p12:
P12_ASFB7.
Cellular proteins in ENSEMBL database: Pak1: EN-
SMMUG00000001387; Rac1: ENSFM00250000002337; b-ac-
tin: ENSMMUG00000012054; Akt: ENSMMUG00000001041;
Rock1: ENSFM00540000717933.
ASFV Entry by Macropinocytosis
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ASFV induces membrane ruffles and blebs to enter host
cells
Macropinocytosis mainly differs from other endocytic processes
in the requirement of extensive actin cytoskeleton restructuring and
formation of blebs or ruffling in the cellular surface, through which
the specific cargo enters the cell [22]. These rearrangements are
coupled to an external-induced formation of plasma membrane
extensions. Several viruses have been described to use macro-
pinocytosis for entry, including Vaccinia virus [23,45,46], Ebola
virus [47] and Kaposi’s sarcoma-associated herpesvirus [29,48].
Receptor-mediated endocytosis has been postulated in classic
studies as the most likely mechanism for ASFV entry into Vero
cells [33–35]. Yet the specific characteristics to further depict the
viral entry procedure have not been elucidated. To analyze the
possible perturbation of the cellular membrane induced by ASFV,
the virus strain Ba71V was used to synchronously infect Vero cells
at MOI 50. To achieve this, we have analyzed by Field Emission
SEM analysis (FESEM) the induction of ruffling and bubbles-like
perturbations at 10, 60 and 90 min after ASFV uptake. The results
are shown in Figure 1A, where a maximum level of membrane
perturbation similar to ruffles appears in ASFV-infected Vero cells
between 10 and 60 mpi, decreasing after 90 mpi, indicating that
ASFV-induced macropinocytosis is a transient event.
On the other hand, Figure 1B shows that ASF virions
internalize in Vero cells adjacent to retracting ruffles, thus
indicating that the macropinocytic uptake of viral particles seems
to occur as part of the macropinocytic process.
Finally, we have analyzed in vivo in real-time the membrane
protrusions observed during Ba71V infection in Vero cells.
Figure 1C shows the sequence of images during the first minutes
of the infection (Video S2), illustrating the ASFV-induced ruffling,
and in concordance with the data shown in Figure 1A. For
comparison to Mock-infected Vero cells, see Video S1.
To assess whether the ASFV entry also induces membrane
perturbation in swine macrophages, the natural target cell of
ASFV infection in vivo, the virulent strain E70 was used to
synchronously infect IPAM cells at MOI 50. As early as 10 mpi,
strong membrane protrusions were observed by FESEM analysis
(Figure 2A). To better characterize these membrane rearrange-
ments, IPAM cells were synchronously infected with E70 strain at
MOI 50, during 30, 45 and 60 mpi. Next, IPAM cells were fixed
and analyzed by optic microscopy. Figure 2B shows images
compatible with blebs induced by ASFV infection in swine
macrophages from 30 mpi. To prove this point, we achieved an
additional experiment showing the inhibition of virus entry with
different doses of blebbistatin, an inhibitor of blebbing and
macropinocytosis [23,29,49–51]. Western blot analyses have
shown that blebbistatin impairs the entry of the virus in IPAM
cells, as the drug inhibits the expression of ASFV proteins when
preincubated before virus addition. Hence, when blebbistatin was
incubated 60 min after virus addition, a much lower inhibition of
viral proteins was observed, thus indicating the role of blebbistatin
on early steps of virus entry. Results are presented in Figure 2C.
Last, by using a specific anti-Rock1 antibody as a marker of
blebs [52], we have shown that Rock1 colocalizes with virus
particles on blebs in IPAM cells from 30 min after ASFV uptake
(Figure 2D), revealing the close relation between bleb and viral
particle.
Taken together, these data strongly indicate that ASFV induces
a vigorous plasma membrane activity during the first steps of the
infection, both in Vero and IPAM cells, well-matching with
macropinocytosis-mediated entry.
ASFV entry is dependent on Na
+/H
+ membrane
exchangers and stimulates uptake of fluid phase markers
With the membrane perturbation pattern shown above, it was
likely that ASFV was using macropinocytosis to enter cells.
Macropinocytosis is dependent on the Na
+/H
+ exchanger [21],
and thus amiloride and its analogue 5-(N-ethhyl-n-isopropil)-
amiloride (EIPA) are frequently used as the main diagnostic test to
identify macropinocytosis because this drug has been shown to be
specific to this endocytic pathway without affecting others [53–55].
Consequently, to further assess the involvement of macropinocy-
tosis in ASFV entry, the effect of EIPA was investigated. When
tested on Vero cells, EIPA had no significant cytotoxic effect as
assessed by cell monolayer integrity and trypan blue cell viability
assessment (Table S1).
It has been previously described that after 60 mpi more than
90% of the ASF viral particles are located in the cell [34].
Furthermore, the viral uncoating does not completely occur before
2 hours post infection (hpi) [34]. According to these data, we
measured viral uptake by using the specific antibody 17LD3
against p72, the major protein of ASFV capsid [42,56] (see
Materials and Methods and Figure S1A, B and C). Interestingly,
amounts of EIPA from 40 mMt o6 0mM caused a significant
reduction (60%) in the uptake of ASFV infective particles after
60 mpi (Figure 3A), suggesting that ASFV entry depends on Na
+/
H
+ exchanger activity/function.
To further visualize the effect of EIPA on virus uptake, Ba71V
strain was added to Vero cells, previously treated with DMSO or
60 mM EIPA. Sixty min after infection, the cells were incubated
with anti-p72 antibody 17LD3 to stain the virus. A confocal
microscopy analysis revealed that there was a noticeable drop in
virus particles incorporated into the cells incubated with EIPA, as
compared to those incorporated into DMSO-incubated cells
(Figure 3B, bottom panels). Images were taken as a maximum z-
projection (x–y plane). For clarification, individual channels are
shown in Figure S2A. Moreover, we also analyzed images of a
maximum z-projection of vertical slices to determine whether viral
particles could be imbibed into the membrane in the presence of
the inhibitor. As shown in the Figure 3B upper panels, a different
distribution of viral particles in the cells infected in the presence of
EIPA, compared to that found in cells infected in the absence of
the drug, was observed. This last data strongly suggests that in
EIPA-treated cells the virus can bind to the membrane but is not
able to internalize. This could be the explanation for the
percentage of cells that were positive for 17LD3 antibody detected
in Figure 3A. The total number of virus obtained in the confocal
images was automatically quantified using a macro algorithm in
the Image J program (Figure S3).
In regard to this, it is also remarkable that, although a small
amount of viral particles can still be detected inside the cells in the
presence of EIPA, neither early, p32, nor late ASFV proteins, p17,
p24, p12 and p72 [57–60] could be detected by Western blot in
the presence of the drug (Figure 3C). Hence, it is likely that EIPA
is mainly affecting virus uptake since when drug is added 60 min
after virus uptake, it does not affect the viral protein synthesis
(Figure S4A). As expected, no viral factories detected by using anti-
p72 antibody (green) and Topro3 (blue) for viral and cellular
DNA, were found after EIPA treatment by confocal microscopy
(Figure 3D). Separate channels are shown in Figure S2B and a
morphological detail of an ASFV factory is shown in Figure S1C.
Consequently, viral production was also strongly inhibited by the
drug (Figure 3E). Finally, and to fully ascertain if EIPA was
specifically blocking ASFV entry and not a downstream step, we
performed the infection by using the acid-mediated fusion of
plasma membrane. Briefly, in the presence of acid pH, endocytosis
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PLoS Pathogens | www.plospathogens.org 5 June 2012 | Volume 8 | Issue 6 | e1002754Figure 1. Ruffles induction upon ASFV entry in Vero cells. A) Field Emission SEM of mock-infected and infected cells. Cells were serum starved
for 24 h and synchronously infected for 10, 60 and 90 min (MOI 50). A magnification of the cell surface detail (boxes) is shown in the lower right
panels. Arrowheads indicate ruffles and arrows indicate bubble-like membrane perturbations. B) TEM of purified viral particle (arrows) localized into
ruffles (arrowheads) in the cells after binding for 90 min at 4uC (MOI 3000). C) Ruffle induction upon ASFV binding to Vero cells. After being serum
starved for 24 h, virus binding was allowed for 90 min at 4uC (MOI 100), and infected cells were recorded during 30 min after warming at 37uC with a
206objective. Time stamps indicate min: sec.
doi:10.1371/journal.ppat.1002754.g001
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PLoS Pathogens | www.plospathogens.org 6 June 2012 | Volume 8 | Issue 6 | e1002754Figure 2. Blebs induction upon ASFV entry in IPAM cells. A) Field Emission SEM of mock-infected and infected cells. Cells were synchronously
infected for 10 min (MOI 50) with E70 after serum starved for 24 h. Membrane perturbations are indicated by arrowheads. A magnification of the cell
surface detail (boxes) is shown in the lower right panels. Bars: 1 mM. B) After synchronic infection at different times (E70, MOI 50), the cells were fixed
and blebs formation (arrowheads) was analyzed by Phase Contrast Microscopy using a 636objective. C) Blebbistatin treatment inhibits ASFV entry.
Cells were treated with DMSO or Blebbistatin 60 min before the infection (Pre) or treated 60 min after virus addition (Post) and maintained during the
infection, at indicated concentrations. After 16 hpi (Ba71V, MOI 1) equivalent amounts of protein were analyzed by immunoblotting with an anti-
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PLoS Pathogens | www.plospathogens.org 7 June 2012 | Volume 8 | Issue 6 | e1002754is subverted and virions fused with the plasma membrane and then
directly carried into the cytosol. When an inhibitor blocks virus
endocytosis, inhibition of viral protein synthesis in the presence of
drug can be bypassed through fusion. If membrane fusion could
not rescue viral gene expression, the blocking would most
probably occur at a post-entry step [23]. By using this method,
we find that when the viral adsorption is performed in the presence
of EIPA in acidic pH, p72 viral synthesis is clearly recovered in
relation to the infection developed at neutral pH (Figure 3F).
Next, we investigated the dextran uptake during ASFV
infection, since it has been described that macropinocytosis
activation induces a transient increase of this fluid phase marker
[61,62]. To achieve this, Vero cells were treated with EIPA for
60 min and then infected synchronously with Ba71V for 30 min,
or stimulated with PMA as a positive control. Fifteen minutes
before stopping the infection, cells were pulsed with dextran and
prepared for FACS analysis. As indicated in Figure 3G, ASFV
infection induces dextran uptake during the virus entry and this
action is inhibited by EIPA. Moreover, to reinforce the hypothesis
that ASFV entry occurs mainly by macropinocytosis, we
developed an experiment to assess the colocalization between
the virus particles and the macropinocytosis marker dextran.
These results are included in Figure 3H.
All together, these data strongly indicate that ASFV induces
activation of macropinocytosis to enter cells.
Chemical disruption of actin cytoskeleton inhibits ASFV
entry
Macropinocytosis is a very specific actin-dependent endocytic
process since it depends on acting rearrangements to induce
membrane ruffling formation, and inhibitors of actin microfila-
ments, such as Cytochalasin D (Cyto D) [63,64], Latrunculin A
[65] and Jasplakinolide [66], are commonly used to inhibit this
process.
To demonstrate whether ASFV depends on actin to enter cells,
we used Cyto D, which binds to the positive end of F-actin
impairing further addition of G-actin, thus preventing growth of
the microfilament [67]. Vero cells were pretreated with Cyto D at
a concentration of 8 mM and ASFV uptake (MOI 10) at 60 mpi
was next analyzed by FACS. As shown in Figure 4A, the
disruption of actin dynamics by the inhibitor reduced ASFV entry
in a percentage of about 50%. To assess whether the drug impairs
the synthesis of viral proteins, Vero cells were untreated or treated
with Cyto D (4 mM) and then infected with Ba71V, MOI 1. After
16 hpi, we used a specific antiserum against both early and late
ASFV proteins (generated in our lab), to analyze viral protein
expression. As expected, Cyto D treatment importantly reduced
both the synthesis of p32, one of the main ASFV early proteins,
and the synthesis of p12, p17 and p72, three typical late proteins in
the ASFV cycle (Figure 4B). In agreement with this, both virus
production and viral factories clearly diminished as shown in
Figure 4C and 4D, respectively. However, it is noteworthy that
even in the presence of Cyto D, a number of virions seem able to
enter the cell and induce a productive infection, thus suggesting
that the actin cytoskeleton is involved in ASFV entry and also in
successive post-entry steps, as shown in Figure S4B.
To further assess the importance of actin microfilaments in the
first steps of ASVF entry, we examined whether ASFV infection
causes rearrangements of actin cytoskeleton in Vero cells, by using
phalloidin in confocal microscopy experiments. Data are present-
ed in Figure 4E, showing the change of actin pattern after 10 and
30 min after virus uptake at MOI 50. Furthermore, and to
reinforce these data, Vero cells were transfected with pEGFP-actin
plasmid (kindly gifted by Dr. J. Mercer), and infected with Ba71V,
MOI 50. Figure 4F shows the redistribution in aggregates of GFP-
actin in transfected Vero cells, which are similar to those observed
when endogenous actin was analyzed. Not only that, but also, viral
particles (red) are found together with the actin aggregates both in
endogenous and ectopically expressed actin.
Since it has been described that blebs and ruffles contain actin,
Rac1 and cortactin [23,68], it is likely that these actin spots
correspond to membrane active places where ASFV-induced
ruffling should occur, thus suggesting that actin dynamics is a very
important factor to ASFV in the host cell to mediate cell-wide
plasma membrane ruffling.
Another component of the cytoskeleton that has been reported
to be involved in several virus entry processes is the microtubules
system, although the importance of microtubules specifically
regarding the macropinocytosis pathway is controversial [69]. In
respect to ASFV infection, whereas it has been reported that
nocodazole (a specific inhibitor of microtubules system [70]) does
not affect viral DNA replication [71], a report from Health et al.
[72] describes that nocodazole produces a decrease in the
expression of p72 and p12 late proteins, but not in the early
proteins of ASFV. To investigate whether the microtubule system
has a role in ASFV entry, Vero cells were treated with different
concentrations of nocodazole and then infected with ASFV at
MOI 1. Microtubule disruption had no effect on early viral protein
synthesis and barely on late proteins synthesis such as p12 and p72
(Figure S5). Therefore, we conclude that the microtubules system
is not likely significant for ASFV entry.
ASFV induces EGFR and PI3K-Akt pathway activation
Macropinocytosis is typically started by external stimulation. This
stimulation is usually associated with growth factors that trigger
activation of receptor tyrosine kinases (RTKs). These molecules then
activate signaling pathways that induce changes in the dynamics of
actin cytoskeleton and disturb plasma membrane [21]. Among them,
epidermal growth factor receptor (EGFR) has been connected with
actin rearrangement and activation of Rho family GTPases, and its
activation is known to trigger macropinocytosis [45,73].
Besides the membrane perturbations and actin remodeling
observed following ASFV uptake, we have found that EGFR
activation was essential for ASFV infection, since 324674, the
specific inhibitor of this receptor tyrosine kinase [74], efficiently
inhibited ASFV uptake in a dose-dependent manner as assessed by
FACS experiments in Vero cells. Accordingly, ASFV entry relies
on tyrosine kinases activity, as preincubation of the cells with
genistein (tyrosine kinase inhibitor [75]) also inhibited ASFV
infection (Figure 5A).
The PI3K/PDK1/Akt/mTORC1 pathway regulates vital
cellular processes that are important for viral replication and
propagation, including cell growth, proliferation, and protein
ASFV antibody. b-actin was detected as a load control. Fold induction was determined by densitometry (mean 6S.D) as shown in the graphic below.
D) Rock1 colocalizes with ASFV in blebs (arrows). Cells were infected (Ba71V, MOI 50) and fixed at 30 min after infection. Cells were incubated with,
anti-Rock1 (red), anti-p72 (green) and Topro3 (blue) to stain blebs, virus and nuclei, respectively. Images were taken by CLSM and represented as a
maximum z-projection of x–y plane and Normasky. Magnifications of the bleb containing Rock1 and viruses (boxes) are shown in the corresponding
bottom panels. S.D., standard deviations.
doi:10.1371/journal.ppat.1002754.g002
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PLoS Pathogens | www.plospathogens.org 8 June 2012 | Volume 8 | Issue 6 | e1002754translation [76]. Concerning macropinocytosis, it has been
described that PI3K and its effectors induce the formation of
lipid structures in ruffles and macropinocytic cups involved in
cytoskeleton modulation [77–79]. In recent years, it has been
reported that several viruses use the PI3K-Akt pathway to support
entry into cells and early events of the infection [23,80].
Figure 3. EIPA treatment inhibits ASFV entry and infection in Vero cells. A–B) EIPA inhibits ASFV uptake. Cells were pretreated (DMSO or
EIPA) and infected (MOI 10) for 60 min. A) Infected cells were analyzed by FACS. Graphic shows percentage of virus entry relative to DMSO control,
measured as p72 signal. (n=7, performed in duplicate; mean6S.D.) B) Cells were incubated with Topro3, TRITC-phalloidin and anti-p72 to stain nuclei
(blue), actin filaments (red) and viral particles (green), respectively. Images were taken by CLSM and represented as a maximum z- projection of x–y
plane (bottom panels) and x–z plane (upper panels). C–E) The infection is inhibited by EIPA. C) Pretreated cells (20 mM EIPA) were infected (MOI 1) for
16 h and analyzed by immunoblotting with an anti-p72 and an anti-ASFV polyclonal antibodies. D) Pretreated cells (60 mM EIPA) were infected (MOI
5) and stained with Topro3, TRITC-phalloidin and anti-p72. Images were taken by CLSM (mid z-section). Arrowheads: viral factories. E) Supernatants
from pretreated (20 mM EIPA) and infected cells (MOI 1) were recovered and lytic viruses were titrated (n=3, mean 6S.D). F) Bypass of EIPA of ASFV
infectivity. Acid mediated bypass was performed and samples of pretreated (20 mM EIPA) and infected cells (MOI 1) for 16 h were analyzed by
immunoblotting with an anti-ASFV antibody. G–H) ASFV colocalizes with dextran and induces its uptake. G) Cells were pretreated (60 mM EIPA) and
infected (MOI 10) or stimulated with PMA for 30 min, pulsed with 647-dextran for 15 min and analyzed by FACS (n=3; mean 6S.D.). H) After 30 mpi
cells were pulsed with Texas-red-dextran for 15 min and incubated with anti-p72 antibody. Images were taken by CLSM (mid z-section) and
Nomarsky. Arrowheads: dextran-virus colocalization. b-actin: load control. S.D., standard deviations.
* Unspecific cellular protein detected by the
antibody.
doi:10.1371/journal.ppat.1002754.g003
ASFV Entry by Macropinocytosis
PLoS Pathogens | www.plospathogens.org 9 June 2012 | Volume 8 | Issue 6 | e1002754Figure 4. Actin dynamics is important for first steps during ASFV entry in Vero cells. A–D) Disruption of actin dynamics reduces the entry
of ASFV. A) Uptake assays were performed by FACS. Pretreated cells with DMSO or 8 mM Cyto D were infected (MOI 10) for 60 min. Graphic shows
percentage of virus entry relative to DMSO control, measured as p72 signal (n=3, performed in duplicate; mean 6S.D). B) Cells were pretreated
(4 mM Cyto D) and infected (MOI 1) for 16 h. Equivalent amounts of protein were analyzed by Western blot with an anti-ASFV antibody. b-actin was
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PLoS Pathogens | www.plospathogens.org 10 June 2012 | Volume 8 | Issue 6 | e1002754In order to investigate the importance of this pathway on ASFV
entry, we have developed, after different times of ASFV uptake, an
ELISA test that directly measures the activity of PI3K by analyzing
phosphorylation of its specific substrate PI(4,5)P2. The results
(Figure 5B), show the increase of substrate phosphorylation from
5 min after virus uptake, reaching a maximum after 30 min of
infection. Importantly, the presence of the PI3K inhibitor LY294002
(LY) [81] strongly impaired the kinase activation by the virus.
It has been reported that Akt is the major downstream effector
of the PI3K pathway and is commonly used as readout of PI3K
activation [82], since Akt phosphorylation has been considered to
be a direct consequence of PI3K activation pathway [83–85]. To
analyze the effect of virus uptake on Akt phosphorylation, Vero
cells were serum starved for 4 h and then infected with Ba71V
(MOI 10) from 5 to 90 min. Figure 5C shows that Akt is
phosphorylated from 5 min after virus uptake, reaching a
maximum at 30 min. It has been established that Akt phosphor-
ylation of Thr308 is a direct consequence of PI3K activation
pathway [83] while phosphorylation of Ser473 depends on
mTORC2 [84,85]. Since phosphorylation in both residues of
Akt is required for its complete activation, we measured the
ASFV-induced Akt phosphorylation with two different anti-
phospho antibodies. Figure S6 shows that Akt is phosphorylated
both in Thr308 and in Ser473 early after ASFV infection,
suggesting that ASFV entry fully activates this pathway in the
infected cell.
To further investigate whether the PI3K activation observed
early during ASFV infection involves mainly upstream steps, we
pretreated Vero cells with LY at a concentration of 60 mM. Cells
were then infected with Ba71V MOI 10, and the virus uptake was
analyzed by FACS at 60 mpi. Figure 5D shows that virus uptake
decreased to about 45% in treated Vero cells in respect to DMSO-
treated cells, indicating that PI3K activation is involved in the
virus entry. Not only that, but we also found that the activation of
this kinase has a key role in the consecution of infection since, as
shown in Figure 5E, the presence of 20 mM LY severely impairs
the synthesis of both ASFV early and late virus proteins. Recently,
our group has described that ASFV regulates the cellular
machinery of protein synthesis to guarantee the expression of its
own proteins [15]. Since it has been reported that one of the main
roles of PI3K is regulating the translational machinery through the
PI3K-Akt-mTOR pathway [86], the strong effect observed of LY
on the ASFV protein synthesis is not surprising (Figure S4C).
Finally, and to confirm the role of PI3K on ASFV infection, we
performed experiments to analyze the number of cells presenting
viral factories in the presence of LY. As shown in Figure 5F, a
dramatic decrease of infected cells was observed after 16 hpi (MOI
5) when the infection was performed in the presence of the
inhibitor. Similarly, virus production was diminished about 3 logs
units by the effect of LY after 48 hpi (Figure 5G).
ASFV triggers Rac1 activation to enter into the host cells
Since activation of Rac1-GTPase has been involved in the
regulation of macropinocytosis by triggering membrane ruffling in
the cell [87], we investigated the activation status of Rac1 during
the first steps of ASFV entry in Vero cells. Ba71V was used to
synchronously infect cells (MOI 10), and Rac1 activation was
measured with the G-LISA activation kit following the manufac-
turer’s instructions. The results showed that Rac1 activation is a
very fast and strong event during ASFV entry, reaching a
maximum (2.5 fold) at 10 mpi compared to mock-infected cells
(Figure 6A). It has been shown that Rac1 controls macropinocy-
tosis by interacting with its specific effectors, the p21-activated
kinases (Paks), thus modulating actin cytoskeleton dynamics
[88,89]. It is also known that Rac1 binds and activates Pak1 only
under its Rac1-GTP active form. To confirm the results obtained
by G-LISA, we further analyzed the Rac1 activation during ASFV
entry by performing a pull down assay using Pak1-PBD-Agarose
Beads, which carried the PBD-Pak1 ready to bind Rac1-GTP. As
shown in Figure 6B, Rac1-GTP was found together with the
pulled Pak1-PBD-Agarose Beads after 10 min post ASFV
infection, slightly diminishing 30 min after the infection. This
result further corroborates that ASFV entry induces the formation
of the Rac1 active conformation. Since it has been described that
Rac1 is contained in blebs and ruffles [22,23,90] and, as shown
above, ASFV induces these type of the structures when it infects
cells, we next analyzed the localization of Rac1 during the process
of ASFV entry. To achieve this, Vero cells were first transfected
for 24 h with pEGFP-Rac1 (kindly given by Dr. J. Mercer) and
then infected with Ba71V, MOI 10. As shown in Figure 6C, we
found clusters of the GTPase as early as 10 min after infection.
Accordingly with the experiments shown above, this effect was
clearly perceptible at 30 mpi, demonstrating, first, that ASFV
infection induces accumulation of active Rac1 in ruffling areas,
and second, that this is an event that takes place mainly during
ASFV entry.
The effect of Rac1 inhibition on virus uptake was next
investigated. Cells were pretreated with 200 mM Rac1 inhibitor
[91] and the virus uptake was measured after 60 mpi by FACS
analysis, using the specific antibody against the ASFV capsid
protein p72, as described in Materials and Methods. Figure 6D
shows the dramatic decrease of virus uptake when the infection is
performed in the presence of the pharmacologic inhibitor of Rac1.
Furthermore, we analyzed the effect on the ASFV uptake in the
presence of the inhibitor by CLSM experiments, using the same
conditions as above. The images were taken as a maximum z-
projection of horizontal and vertical slices. As Figure 6E (bottom
panels) indicates, a strong inhibition of virus uptake could be
observed in the presence of the Rac1 inhibitor, since the number
of ASFV particles in the cell (green) is visibly lower in the presence
of the drug. Moreover, and as shown in the upper panels of
Figure 6E, virus (green) colocalized (yellow), with cortical actin
(red), indicating that the drug immobilizes the virions imbibed into
the plasma membrane and impairs their entry into the cell.
Separated channels are also shown in Figure S2D.
Alternatively, and to reinforce the role of Rac1 on ASFV
infection, we studied the level of ASFV protein synthesis in Vero
cells previously transfected with the mutant pGFP-Rac1-N17 (a
detected as a load control. C) After 48 hpi (MOI 1) supernatants from treated cells (8 mM Cyto D) were recovered and lytic viruses were titrated (n=3,
mean 6S.D). D) Development of viral factories (arrowheads) was analyzed by CLSM after treatment (8 mM Cyto D) and infected (MOI 5) for 16 h. Fixed
cells were stained with Topro3 (blue), TRITC-phalloidin (red), and anti-p72 (green) to visualize cell nuclei, actin filaments and viral factories,
respectively. Images of a mid z-section are shown. The percentage of infected cells of three independent experiments from CLSM images (100 cells
per condition) is represented in graphic format (mean 6S.D.). E–F) ASFV infection induces rearrangements of the actin cytoskeleton. Cells were
infected at a MOI of 50 pfu/cell (E) or transfected with pEGFP-actin for 16 h and then infected (MOI 50). For both, E and F, cells were fixed at indicated
times post infection and incubated with Alexa Fluor 488-phalloidin (E), anti-p72 and Topro3 (E and F) to stain actin filaments, viral particles and cell
nuclei, respectively. Z-slides images were taken by CLSM and represented as a maximum of z-projection. S.D., standard deviation; Cyto D,
Cytochalasin D.
* Unspecific cellular protein detected by the antibody.
doi:10.1371/journal.ppat.1002754.g004
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of Rac1 strongly inhibited the expression of the ASFV early p32
protein (Figure 6F). As expected, the synthesis of viral late proteins
was also affected by treatment with the inhibitor (Figure S7). Not
only that, but also, when Rac1 inhibitor was added 60 min after
virus addition, the level of viral protein synthesis observed was
completely recovered, thus reinforcing the role of Rac1 in virus
entry (Figure S4D).
Hence, the role of Rac1 on ASFV morphogenesis and virus
production was investigated. To achieve this, Vero cells were
treated with the Rac1 inhibitor and then infected during 16 h,
MOI 5. Cells were fixed and stained with anti-p72 to visualize the
viral factories by CLSM and the percentage of infected cells in the
presence or absence of the inhibitor was represented in the graph
(Figure 6G). As observed, the number of cells containing ASFV
factories decreased about 65% in the presence of Rac1 inhibitor
compared to the untreated controls (separate channels are shown
in Figure S2E). In line with these results, the viral production at
48 hpi decreased strongly when the activity of Rac1 GTPase was
inhibited (Figure 6H).
Figure 5. Role of PI3K-Akt, EGFR and tyrosin kinases on ASFV entry and infection in Vero cells. A) EGFR and tyrosin kinases are important
for ASFV uptake. Virus entry was measured by FACS in cells pretreated with 324674 and Genistein after 60 mpi (MOI 10). Graphic shows percentage
of virus entry relative to DMSO control, measured as p72 signal (n=3, performed in duplicate; mean 6S.D.). B) PI3K is activated during ASFV entry.
Pretreated cells (DMSO or 40 mM LY) were infected (MOI 10) and PI3K activity was measured by ELISA kit at indicated times post infection. C) ASFV
infection induces Akt phosphorylation. Cells were infected (MOI 10) and phosphorylation level of Akt was analyzed by immunoblotting with a
phospho-Akt Ser473 antibody. Total Akt levels were measured as a control and fold induction was determined by densitometry (mean6S.D). D) PI3K
is required for ASFV entry. Cells were pretreated (60 mM LY) and infected (MOI 10) for 60 min to analyze ASFV uptake by FACS. Graphic shows
percentage of virus entry relative to DMSO control, measured as p72 signal (n=4, performed in duplicate; mean 6S.D.). E) PI3K plays an important
role in viral protein synthesis. Cells were pretreated (20 mM LY) and infected (MOI 1) for 3 and 16 h. Viral protein synthesis was analyzed with anti-p32
and anti-p72 polyclonal antibodies by immunoblotting. Phospho-Akt and b-actin were measured as controls. F) LY inhibits viral factory development.
Infected cells (MOI 5) were pretreated (60 mM LY) and viral factories (stained with anti-p72 at 16 hpi) were analyzed by CLSM. 100 cells per condition
were counted and data represented by the graphic (n=3, mean 6S.D). G) Viral production in the presence of LY. Supernatants from treated cells
(20 mM LY) were recovered after 48 hpi (MOI 1) and lytic viruses were titrated (n=3, mean 6S.D). S.D., standard deviations; LY, LY294002.
doi:10.1371/journal.ppat.1002754.g005
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PLoS Pathogens | www.plospathogens.org 13 June 2012 | Volume 8 | Issue 6 | e1002754Finally, since Rac1 has been reported to be an important
component of ruffles [22,23,90], we have used the Rac1 inhibitor
to assess its involvement in the inhibition of these membrane
perturbations and therefore, indirectly, the role of ruffles in ASFV
uptake. To achieve this, we have performed FESEM assays in
Vero cells treated with 200 mM Rac1 inhibitor during 60 min
prior to virus addition. As shown in Figure 6I, Rac1 inhibitor
strongly decreases the ASFV-induced ruffles, in accordance with
the decrease in virus uptake (Figure 6D), viral infection (6G) and
virus production (6H) previously observed.
Taken together, these results demonstrate the significant role of
Rac1 on ASFV entry.
Pak1 activation has a key role in ASFV infection
The p21-activated kinase 1 (Pak1), a serine/threonine kinase
activated by Rac1 or Cdc42 [89] is one of the most relevant
kinases related to several virus entry processes since it is involved in
the regulation of cytoskeleton dynamics and is needed during all
the stages of macropinocytosis [88,92,93]. Among the different
residues to be phosphorylated in Pak1 activation, the Thr423 plays
a central role because its phosphorylation is necessary for full
activation of the kinase [94].
To determine whether Pak1 was activated during ASFV entry,
we first analyzed the phosphorylation on Thr423 in Vero cells
synchronously infected (MOI 5) with Ba71V. At different times
post infection, samples were collected and analyzed by immuno-
blotting using an anti-phospho-Pak1 Thr423 antibody. As early as
30 mpi, phosphorylation of Pak1 could be detected, increasing
until 120 mpi (Figure 7A).
IPA-3 has been identified as a direct, noncompetitive and highly
selective Pak1 inhibitor. In the presence of IPA-3, Thr423
phosphorylation is inhibited since the Pak1 autoregulatory domain
is targeted by the inhibitor [95]. To assess the role of Pak1
activation in ASFV uptake, we measured by FACS analysis the
p72 levels detected into the Ba71V-infected Vero cells (MOI 10)
after 60 mpi. As shown in Figure 7B, the p72 levels incorporated
into the cells in the presence of 30 mM IPA-3 were significantly
lower (70%) than those obtained in the absence of the inhibitor.
These results indicate that Pak1 activation is involved in the first
stages of ASFV entry, since phosphorylation of the kinase occurs at
very early times after virus addition, and even more importantly,
the uptake of the virus into the host cells is strongly dependent of
Pak1 activity.
Apart from the role played by Pak1 in viral entry, the sensitivity
of ASFV infection to IPA-3 was investigated in Ba71V-infected
Vero cells by Western blot. Using specific antibodies against both
early and late ASFV proteins, the effect of the inhibitor from 1 to
10 mM on viral protein synthesis was evaluated. Figure 7C shows
the strong dose-dependent IPA-3 inhibition over the most
important early (p32) and late proteins (p72, p24, p17 and p12).
To reinforce the role of Pak1 in ASFV entry, a similar experiment
performed by incubation with IPA-3 during 60 min after virus
addition is shown in Figure S4E. These data indicate that the drug
is mainly affecting virus entry as it does not induce important
inhibition on viral protein synthesis when incubated after virus
uptake. Moreover, virus title was reduced 1.5 log units in cells
pretreated with 5 mM IPA-3 and then infected with Ba71V (MOI
1) in the presence of the inhibitor during 48 h (Figure 7D).
To corroborate the significant role of Pak1 during ASFV
infection, we used different Pak1 constructs affecting Pak1
activation (see Materials and Methods). Vero cells were transfected
for 24 h with pEGFP, pEGFP-Pak1-WT, pEGFP-Pak-AID and
pEGFP-Pak1-T423E (all of them kindly gifted by Dr. J. Chernoff)
and infected for 16 h with ASFV at a MOI of 1 pfu/cell. As
shown in Figure 7E, the constructs containing the Pak1
autoinhibitory domain (AID) inhibited p12 and p32 viral protein
expression, whereas cells transfected with wild type (WT) form
showed the same protein levels than infected control cells. It is
noteworthy that constitutively active Pak1 construction T423E
(even although it was only shortly expressed in the transient
transfection process) induced a remarkable enhancement on the
expression of the ASFV early protein p32, indicating that
increasing Pak1 activity intensifies the early protein synthesis,
probably due to its effect on virus entry. Numeric values of these
data are shown in Figure 7F.
These data, together with those of Rac1 activation explained
above, strongly supports our hypothesis of ASFV triggering the
Rac1-Pak1 pathway during the virus entry.
Role of dynamin and clathrin during ASFV entry and
infection
Dynamin is a cellular essential GTPase which plays an
important role in cellular membrane fission during vesicle
formation [96]. It is likely involved in Rac1 localization and
function, since it has been shown that Rac1-dependent macro-
pinocytosis is blocked by the dynamin-2 (DynK44A) dominant-
negative [39].
Since, as we demonstrated above, Rac1 is important to ASFV
entry, we have analyzed whether dynamin-2 pathway plays a role
either in ASFV entry or infection. To achieve this, we first
investigated the effect of Dynasore (Dyn), a reversible inhibitor of
GTPases activity [97], over ASFV uptake. After 60 min of
pretreatment with 100 mM Dyn, Vero cells were infected with
Ba71V at MOI 10 and virus uptake was measured by FACS using
the specific antibody against the capsid viral protein p72. The
result showed that treatment with Dyn partially inhibited virus
uptake (35%) (Figure 8A). A higher effect of the inhibitor on ASFV
entry could not be found by using different experimental
Figure 6. Rac1 plays a critical role in ASFV entry in Vero cells. A–B) Activation of Rac1 during ASFV entry. Vero cells were infected (MOI 10)
and 0.Rac1 activation was measured by A) Kit Activation Assay (n=3; mean 6S.D.) and B) Pak1 PBD-Agarose Beads pull down assay. Fold induction
was determined by densitometry (mean 6S.D). C) ASFV infection induces clustering of Rac1. Cells were transfected with pEGFP-Rac1, infected (MOI
10) and stained with Topro3 (blue) and anti-p72 (red). Analyzed images by CLSM were represented as a maximum of z-projection. D–E) Rac1 inhibitor
blocks viral entry. Pretreated cells (200 mM Rac1 inhibitor) were infected (MOI 10) for 60 min. D) Graphic shows percentage of virus entry relative to
DMSO control, measured as p72 signal analyzed by FACS (n=3, performed in duplicate; mean 6S.D.). E) Cells were incubated with Topro3 (blue),
TRITC-phalloidin (red) and anti-p72 (green). Images are represented as a maximum z-projection of x-y plane (bottom panels) and x–z plane (upper
panels). F) Expression of inactive form of Rac-1 reduces viral infection. Transfected cells with pcDNA or pGFP-Rac1-N17 were infected (MOI 1) for 16 h.
Viral protein synthesis was analyzed by immunoblotting with an anti-p32 antibody. GFP and b-actin levels were measured as a control. G–H) Rac-1
inhibitor affects ASFV infection. G) Viral factory formation was analyzed in pretreated and infected cells (MOI 5) for 16 h. Cells were fixed and stained
with Topro3, TRITC-phalloidin and anti-p72. Arrowheads: viral factories. Percentage of the infected cells is represented in left graphic (100 cells/
condition; n=3; mean 6S.D.). H) After 48 hpi (MOI 1) supernatants from treated cells were recovered and lytic viruses were titrated (n=3). I) ASFV-
induced ruffles are inhibited by Rac1 inhibitor. Cells were pretreated (200 mM Rac1 inhibitor), infected (MOI 50) for 10 min, fixed and analyzed by
FESEM. S.D., standard deviations.
doi:10.1371/journal.ppat.1002754.g006
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involvement of dynamine in virus uptake. Moreover, the role of
clathrin-mediated endocytosis was examined in parallel using
Chlorpromazine (CPZ), which inhibits the assembly of coated pits
at the plasma membrane and is considered a specific inhibitor of
clathrin-mediated endocytosis [98]. Using parallel experimental
conditions, and in contrast with the data obtained after treatment
with Dyn, we observed that the virus uptake was not likely affected
in the presence of 20 mM CPZ (Figure 8A). These data indicate
that whereas dynamine is to some extent involved in ASFV entry
in accordance with its role in macropinocytosis [39], clathrin is not
related to ASFV uptake in Vero cells.
In order to investigate whether other steps downstream ASFV
entry were affected by Dyn and CPZ, Vero cells were separately
pretreated with the inhibitors, and then infected with ASFV (MOI
1). At the indicated times after infection, the synthesis of both early
and late ASFV proteins was analyzed by Western blot. The
treatment with 100 mM Dyn strongly inhibited p72 and p32
expression from early times post infection (Figure 8B), conse-
quently indicating that dynamine is required for ASFV both early
and late infection course. As Figure 8C shows, CPZ had a similar
effect to Dyn both on ASFV early and late protein synthesis, in
concordance with the data from Hernaez et al. [38], in which the
expression of the viral protein p32 depends on clathrin function.
Higher amounts of CPZ could result in an inhibition of p72, but
this effect is likely due to the cytotoxic effect of the drug, as
reported in Table S1. Taken together, our data showed that
whereas the effect of Dyn on viral protein synthesis is probably due
to dynamine participation on ASFV entry events, the clathrin
inhibition does not involve virus uptake, but only viral protein
synthesis, thus indicating a role for clathrin function merely in post
entry events. Future experiments are planned to more specifically
Figure 7. Pak1 is required for ASFV entry in Vero cells. A) ASFV activates Pak1 at early times post infection. Cells were infected (MOI 5) and
phosphorylation of Pak1 (Thr423) was determined at different times after infection by Western blot. Levels of total Pak1 were measured as a control.
Fold induction was determined by densitometry (mean 6S.D). B–D) IPA-3 inhibits ASFV entry. B) Cells were pretreated with DMSO or 30 mM IPA-3
and infected (MOI 10) for 60 min to analyze ASFV uptake by FACS. The graph shows percentage of virus entry relative to DMSO control, measured as
p72 signal (n=9, performed in duplicate; mean 6S.D.). C) Viral protein synthesis was analyzed in infected cells (MOI 1) at 16 hpi in the presence of
IPA-3 at the indicated concentrations. Equivalent amounts of protein were analyzed by Western blot with an anti-ASFV antibody. D) Supernatants
from DMSO or 5 mM IPA-3 treated cells after 48 hpi (MOI 1) were recovered. Lytic viruses were titrated in Vero monolayers and plotted in the table
(n=3). E–F) Pak1 mutant reduces ASFV infection. E) Vero cells were transfected with pEGFP-Pak1-WT, pEGFP-Pak1-AID (Pak D/N form) and pEGFP-
Pak1-T423E (Pak C/A form) for 24 h. Then, cells were infected (MOI 1) for 16 h and viral protein synthesis was analyzed by immunoblotting with an
anti-ASFV antibody. GFP expression was measured as a control of transfection. b-actin was detected as a load control. F) Fold induction was
determined by densitometry and represented in the graphic (mean 6S.D). S.D., standard deviation.
* Unspecific cellular protein detected by the
antibody.
doi:10.1371/journal.ppat.1002754.g007
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clathrin.
Finally, and as expected, both inhibitors had an important effect
on viral production measured after 48 hpi (MOI 1) in Vero cells
(Figure 8D).
Discussion
Endocytosis constitutes an efficient way for viruses to cross the
physical barrier represented by the plasma membrane and to pass
through the underlying cortical matrix. Knowledge of the specific
pathway of virus entry and of the precise mechanisms regulating is
key to understand viral pathogenesis, since virus entry into host
cell is the first major step in infection. Whereas there is ample
evidence showing that ASFV enters cells through endocytosis in a
pH-dependent manner and that saturable binding-sites on the
plasma membrane mediate the productive entry of the virus into
Vero cells and swine macrophages [33,34], the specific endocytic
and signaling pathways used by the virus are largely unknown.
In this report, by combining different and independent
approaches, we have achieved an exhaustive analysis of the ASFV
endocytic pathway. We have obtained a precise picture of how
ASFV enters the cell and have identified the main cellular proteins
required. Careful assessment of specificity and functionality of
each pathway was performed and correlated with infection and
virus uptake.
Many recent reports have shown that viruses can directly use
macropinocytosis as an endocytic way for productive infection
[21,23–29], and also to promote the penetration of viral particles
that enter by other endocytic mechanisms [31,32]. Macropinocy-
tosis activation is related to significant cell-wide membrane ruffling
mediated by activation of actin filaments. These structures may
have different shapes: lamellipodia, circular-shaped membrane
extrusions (ruffles) or large membrane extrusions in form of blebs.
Here we have illustrated by FESEM that ASFV strain Ba71V
induced prominent membrane protrusions compatible with ruffles
after 10 mpi. Transmission electron microscopy images further
support this result by showing that ASF virions internalize
adjacent to retracting ruffles, likely indicating uptake of viral
particles occurs as part of the macropinocytic process. Not only
that, but also, we found that inhibition of Rac1, an important
component of ruffles, importantly impaired the ASFV uptake, thus
involving the formation of these membrane perturbations in virus
entry.
Moreover, and in parallel to the data obtained in Vero cells, we
found that the E70 virulent strain induced a type of membrane
protrusion similar to blebs a few minutes after the infection of the
swine macrophage line IPAM. This last result is important, since
macrophages are probably the natural target cell of the infection in
vivo and suggests that different macropinocytic programs can be
used by different ASFV strains, as has been published for other
virus as Vaccinia [45]. Because of this, we have carefully
characterized these structures. First, we showed the inhibition of
virus entry with different doses of blebbistatin, and second we
demonstrated that Rock1 (a marker of blebs [52]) colocalized with
virus particles on blebs in IPAM cells from 30 min after virus
uptake.
Apart from characteristic membrane perturbations, macropi-
nocytosis is also distinguished from other entry pathways by
features that include actin-dependent structural changes in the
Figure 8. ASFV entry is independent of clathrin-mediated endocytic pathway. A) ASFV entry is partially inhibited by Dynasore but not by
Chlorpromazine. Pretreated Vero cells with DMSO, 100 mM Dynasore (Dyn) and 20 mM Chlorpromazine (CPZ) were infected (MOI 10) for 60 min.
Infected cells were analyzed by FACS and the graph shows the percentage of virus entry relative to DMSO control, measured as p72 signal. Bars
represent the mean of three independent experiments (mean 6S.D., performed in duplicate). B–C) Dynamin and Clathrin are important for infection
progress. Synthesis of viral proteins was measured in infected Vero cells (MOI 1) in the presence of Dyn (B) and CPZ (C) at 6 and/or 16 hpi at the
indicated concentrations by Western blot with an anti-ASFV antibody. b-actin was detected as a load control. D) Viral production in the presence of
Dynasore and Chlorpromazine. After 48 hpi (MOI 1) supernatants from DMSO, Dyn (100 mM) and CPZ (20 mM) treated cells were recovered. Lytic
viruses were titrated in Vero monolayers and plotted in the table (n=3). S.D., standard deviations; Dyn, Dynasore; CPZ, Chlorpromazine.
*Unspecific
cellular protein detected by the antibody.
doi:10.1371/journal.ppat.1002754.g008
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GTPases, Na
+/H
+ exchangers, Pak1, as well as ligand-induced
upregulation of fluid phase uptake. In this regard, our work
demonstrates that EIPA, a potent and specific inhibitor of the
Na
+/H
+ exchanger [23,53,54,99], severely impairs ASFV infec-
tion and entry. By using FACS analysis we found that EIPA
treatment caused a significant dose-dependent manner reduction
(more than 60%) in the uptake of ASFV infective particles.
Confocal microscopy analysis also revealed that there was an
evident drop in virus particles incorporated into the cells incubated
with EIPA. It is important to note that macropinocytosis is the
only endocytic pathway susceptible to the inhibition of the Na
+/
H
+ exchangers. Thus, these results strongly indicate the involve-
ment of macropinocytosis in ASFV virus entry.
Actin plays a central role in formation and trafficking of
macropinosomes. Cyto D, which binds to the positive end of F-
actin (impairing further addition of G-actin and preventing the
growth of the microfilament [67]), reduced ASFV entry by
approximately 50% and inhibited the synthesis of both early and
late viral proteins, together with viral morphogenesis. However, it
is remarkable that virions that escape from the action of Cyto D
induce a productive infection, thus suggesting that actin cytoskel-
eton is mainly involved in ASFV entry, although it could have a
role in successive post-entry steps.
Corroborating this hypothesis, we have observed that ASFV
infection causes rearrangements of endogenous actin cytoskeleton
in Vero cells as early as 10 min post infection. These data were
reinforced by overexpression of GFP-actin that was concentrated
in aggregates in virus-infected cells. Together, these data provide
evidence for a role of actin in ASFV entry and suggest that the
virus can actively promote localized actin remodeling to facilitate
its uptake through macropinocytosis or a similar mechanism.
The first reports describing the endocytic entry of viruses into
their host cells presumed that incoming viruses took advantage of
ongoing cellular endocytosis processes [16]. However, it is now
clear that several viruses are not only passive cargo but activate
their own endocytic uptake by eliciting cellular signaling pathways.
The activation of these pathways significantly depends on the
interaction of the virus with cellular receptors specific to the type
and activation status of the host cell [100,101]. ASFV, as Vaccinia
virus [21,45], seems to belong to the viruses that actively trigger
their endocytic internalization. In this respect, we have found that
entry of ASFV is dependent on signaling through tyrosine kinases
as EGFR, and activation of PI3K together with Rho-GTPases as
Rac1, which have been all described to be important regulators of
macropinocytosis [69].
Concerning the function of the PI3K pathway, activation of this
kinase early after virus uptake was confirmed by analyzing the
phosphorylation of its specific substrate PI(4,5)P2. Also, phosphor-
ylation of both residues Thr308 and Ser473 of Akt was observed
early after ASFV infection. Besides, pretreatment of Vero cells
with the specific PI3K pharmacological inhibitor LY strongly
inhibited virus uptake at 60 mpi. Not only that, but we also found
that the activation of this kinase has an important role in the
infection, since the presence of LY severely impairs the synthesis of
both ASFV early and late virus proteins. In this regard, our group
has recently described [15] that ASFV uses the cellular machinery
of protein synthesis to express its own proteins. Since it has been
reported that one of the main roles of PI3K is to regulate the
translational machinery through the AKT-mTOR pathway [86],
the strong effect observed of LY on ASFV protein synthesis is very
much expected.
We have also demonstrated that Rac1, a regulatory guanosine
triphosphatase of Pak1, was activated during ASFV entry. Rac1
protein belongs to the Rho family of small guanosine triphospha-
tases, a subgroup of the Ras superfamily of GTPases [102]. In the
last years, several viruses have been described to target Rho-
GTPases activation to enter the host cells, such as Vaccinia virus
[23,45], Ebola virus [80], Echovirus [92] or Adenoviruses type 2
[103], among others. Through interaction with its specific effector
Pak1, Rac1 modulates actin cytoskeleton dynamics and controls
macropinocytosis [88,89]. Consistent with the data reported by
Mercer and Helenius, 2008 [23], showing that active Rac1 is
contained in virus-induced membrane perturations, our results
show that ASFV induces clusters of this GTPase as early as 10 min
after infection. Hence, Rac1 accumulates in ruffling areas very
early during the process of ASFV entry, suggesting that ASFV
targets Rac1 to entry in host cells. In agreement with this
hypothesis, a strong inhibition of virus uptake, in parallel with
ruffle formation, was observed in the presence of the Rac1
inhibitor. Moreover, by performing CLSM experiments, we
showed that the drug immobilized the virus particles imbibed
into the plasma membrane, thus impairing their entry into the cell.
Taken together, these results demonstrate the significant role of
Rac1 on ASFV entry. Our data strongly contrasts with a recent
study [104], which reported that, although Rac1 is activated by
ASFV infection, it is not involved in either ASFV entry or viral
protein synthesis. In that study by Quetglas et al. [104], Rac1
would be responsible of a downstream process that only affected
viral production. The discrepancies about the role of Rac1 in
ASFV entry and infection might be explained by the fact that the
Rac1 inhibitor concentration used does not match with the
amounts usually employed to analyze the role of Rac1 in virus
uptake [80], and it is likely too low to disturb ASFV entry or viral
protein synthesis. Moreover, confocal microscopy images to
measure ASFV uptake were taken as mid z-section, in contrast
to our procedure that includes several z-sections that allow us to
count the total virus particles inside the cells. Finally, important
information regarding the effect of the dominant-negative Rac1-
N17 on viral protein synthesis were not shown in that study, in
contrast to our results described in Figure 6F. Therefore, the
limitations of that work [104] make it difficult to reach any
conclusions about the function of Rac1 on ASFV entry and
infection. Furthermore, in support of our data, we should note that
we have found an important role for Pak1 in Ba71V entry in Vero
cells. Pak1 is a serine/threonine kinase activated by Rac1 or
Cdc42 involved in the regulation of cytoskeleton dynamics and
needed during all stages of macropinocytosis [88,93,105]. Our
results indicate that Pak1 activation is involved in the first steps of
ASFV entry, since phosphorylation of the kinase occurs at very
early times after virus addition, and even more importantly, the
uptake of the virus into the host cells is strongly dependent of Pak1
activity. However, our preliminary studies using the E70 strain did
not show a clear effect of the Pak1-specific inhibitor IPA-3 on the
synthesis of ASFV proteins (data not shown), either in IPAM or in
alveolar swine macrophages. These data suggest that ASFV may
activate other different pathways in macrophages or that IPA-3
cannot be efficient enough to inhibit Pak1 if this kinase is
constitutively activated in these cells [106,107]. Nevertheless, the
synthesis of viral proteins was strongly inhibited in macrophages
after EIPA and LY treatments, indicating that Na
+/H
+ exchangers
and the PI3K pathway are involved in macropinocytosis-mediated
ASFV entry into these cells (Figure S8).
In conclusion, the involvement of the EGFR and PI3K, the
nature of the signaling pathway, the involvement of Rac1, Pak1
and Na
+/H
+ exchangers, and the actin-cytoskeleton rearrange-
ments, all support a macropinocytosis-driven endocytic process for
ASFV entry. In addition, ASFV caused significant induction of
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and colocalization of the internalized ASF virus particles with
dextran was also observed.
The ASFV genome encodes several glycoproteins [108], whose
role in host-cell binding and entry has not yet been described.
However, it has been shown that glycoproteins and lipids are
required for several virus binding and entry steps to the host cells
[23,109,110]. It has been also reported that cellular partners that
bind to specific regions of viral glycoproteins translocate from
intracellular compartments to regulate the susceptibility of
different cells to the infection [111]. These kinds of mechanisms
could explain the differences found among ASFV viral isolates and
their ability to infect different host cells. Future experiments are
planned to study the role of both ASFV glycolipids and the
putative host partners involved in the mechanisms of ASFV entry
and infection of different cell populations.
Dynamin is a large GTPase that is involved in scission of newly-
formed endocytic vesicles at the plasma membrane [112–114].
Although we have shown that dynasore partially inhibits virus
entry, we have found no evidence for a role of clathrin in ASFV
entry despite the use of multiple approaches. The fact that in our
hands dynamin was only partially involved in ASFV entry further
ruled out roles for clathrin or caveolae-mediated pathways, as both
require dynamin activity. Therefore, our data contrast with a
recent study concluding that clathrin-mediated endocytosis is the
major entry pathway for ASFV [38]. The key concern about the
conclusion of this work is that virus entry is merely measured by
the synthesis of ASFV early proteins in the presence of
chlorpromazine, and not by specific analysis of virus uptake.
Moreover, it is important to note that whereas chlorpromazine
disrupts clathrin-coated pits, it may also interfere with biogenesis
of large intracellular vesicles such as phagosomes and macropino-
somes [115].
Here, by combining different and separate strategies we have
carried out a precise analysis of each key endocytic pathway
concerned, obtaining, for the first time, a relatively complete
description of the mechanism by which ASFV enters into a cell,
including identification of several cellular molecules and routes.
We have carefully evaluated the specificity and functionality of
each pathway and correlated them with virus uptake and infection.
Two different strains of ASFV, the virulent E70 and the virulent
Ba71V, adapted to growth in Vero cells, have been used to study
the virus entry mechanism either in swine macrophages or Vero,
respectively.
Several drugs were used to inhibit pathways, but specificity was
evaluated by testing the function of the main pathways after
treatment. Furthermore, highly specific dominant-negative mu-
tants were used to confirm the data obtained by pharmacological
inhibitors. More importantly, all throughout this work either a
FACS-based or a confocal sensitive virus entry assays were used in
discriminating blockage in virus entry versus blockage in
downstream steps of the infection cycle. This is particularly
relevant when using drugs that frequently affect multiple cellular
functions in addition to specific entry.
Overall, our data provide strong evidence that ASFV entry
takes place by a process closely related to macropinocytosis,
adding new and valuable information regarding endocytosis
mechanisms in the context of ASFV entry (plotted in Table 1).
The evidence presented demonstrates for the first time, that
ASFV utilizes a macropinocytosis-like pathway as the primary
means of entry into IPAM and Vero cells. However, we cannot
state that virus entry occurs exclusively by this pathway, especially
in swine macrophages. But our data clearly show that its
disruption blocks the greater part of infection and particle uptake.
Our work also indicates that clathrin-mediated endocytosis plays
at most a minor role in ASFV entry. However, and in accordance
with the data of Hernaez et al. [38], we found that CPZ diminishes
both ASFV early and late protein synthesis, together with viral
production. Thus, our data demonstrate a role for clathrin
function merely in post entry events.
A strong hazard of ASFV dissemination from Sardinia and
Caucasian areas to EU countries has recently appeared, thus
making the progress of knowledge and tools for protection against
this virus urgent. Infection by ASFV is characterized by the
absence of a neutralizing immune response, which has so far
hampered the development of a conventional vaccine. Therefore,
our findings are relevant as they not only provide a detailed
understanding of ASFV entry mechanism, but also identify novel
cellular factors that may provide new potential targets for therapies
against this virus. In parallel, further studies are planned to
Table 1. Comparison of cellular factors and processes involved in ASFV entry/infection.
Cellular factors Perturbants/inhibitors Required for ASFV entry Required for ASFV infection
Na
+/H
+ exchangers EIPA Yes Yes
Actin Cytochalasin D Yes Yes/No
Myosin II Blebbistatin Yes Yes/No
EGFR EGFR inhibitor Yes N/D
PI3K LY294002 Yes Yes
Rac1 Rac1 inhibitor, Rac1-N17 Yes No
Pak1 IPA-3, Pak1-AID Yes No
Tyrosine Kinases Genistein Yes N/D
Dynamin-2 Dynasore Yes Yes
Clathrin Chlorpromazine No Yes
Microtubules Nocodazole No No
Vacuolar acidification Chloroquine, NH4Cl No Yes [36]
Cholesterol MbCD Yes [116] Yes [116]
N/D, designated no data.
doi:10.1371/journal.ppat.1002754.t001
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macropinocytosis pathway, probably useful for vaccine develop-
ment.
Supporting Information
Figure S1 Specificity of p72 antibody and analysis of the
ASFV infection. A) Distribution of the p72 protein in the virus
particle. Purified virus was treated with different buffers as
explained in Materials and Methods. The supernatant (SP) and
pellet (P) of the different treatments was analyzed by immuno-
blotting and p72 protein was detected with a monoclonal antibody
(17LD3). B) The monoclonal antibody 17LD3 recognizes the viral
particles bound to the cell surface. Viral adsorption to cells was
allowed for 90 min at 4uC at a MOI of 10 pfu/cell. Sixty min after
virus addition, cells were stained for 30 min with 594-WGA to
stain the edge of plasma membrane. Cells were stained with anti-
p72 monoclonal antibody without permeabilization and fixed
finally with paraformaldehide. Images were analyzed by CLSM
and represented as a mid z-section. C) Monoclonal anti-p72
antibody 17LD3 is a useful tool to follow the infection at early and
late times post infection. Vero cells were mock-infected or infected
synchronously for 60 min or 16 h at a MOI of 10 pfu/cell and
5 pfu/cell, respectively. At indicated times post infection the cells
were fixed with paraformaldehide, permeabilized and stained with
Topro3 (blue), TRITC-phalloidin (red) and monoclonal anti-p72
(17LD3) (green) to stain cell nuclei, actin filaments and viral
particles (middle panels) or viral factory (bottom panels, arrow-
heads), respectively. Images were taken by CLSM and represented
as a mid z-section.
(TIF)
Figure S2 Separate channels of CLSM experiments. A–
E) Vero cells were pretreated with DMSO or different
pharmacological inhibitors and infected with Ba71V for 60 min
or 16 h, as indicated in the principal figure legends. The virus
uptake or viral factory formation was analyzed by CLSM staining
the cell nuclei with Topro3 (blue), actin filaments with TRITC-
phalloidin (red) and the virus particles or viral factories with anti-
p72 antibody (green). Images were taken by CLSM and
represented as a mid z-section or maximum z-projection as
indicated. A) Figure 3B; B) Figure 3D; C) Figure 4D; D) Figure 6E;
E) Figure 6G. Cyto D, Cytochalasin D; Rac1 Inh, Rac1 inhibitor.
(TIF)
Figure S3 Effect of macropinocytosis inhibitors on
ASFV uptake. Vero cells were pretreated with DMSO or
different pharmacological inhibitors for 60 min at 37uC as follows:
60 mM EIPA, 8 mM Cyto D, 60 mM LY, 200 mM Rac1 Inh and
30 mM IPA-3. Cells were synchronously infected (MOI 10) for
60 min in the presence of the drugs, fixed and stained with Topro3
(blue), phalloidin (red) and anti-p72 (green). Images were taken by
CLSM and represented as a maximum z-projection of horizontal
slices (x–y plane). The LSM images were imported to Image J
program and the number of virus particles inside the cells was
automatically counted with a Macro algorithm in which threshold
Intermodes was used to define a single virus particle in the cell.
The graph shows percentage of virus inside the cells relative to
DMSO control of the three independent experiments (mean
6S.D.). S.D., standard deviations; Cyto D, Cytochalasin D; LY,
LY294002; Rac1 Inh, Rac1 inhibitor.
(TIF)
Figure S4 Effect of macropinocytosis inhibitors on virus
entry and post entry steps. Vero cells were treated with
20 mM EIPA (A), 4 mM Cyto D (B), 20 mM LY (C), 200 mM Rac1
Inh (D) and 10 mM IPA-3 (E) for 60 min before the virus addition
(Pre-treatment, Pre), or 60 min after virus addition (Post-
treatment, Post), and viral infection was allowed in the presence
of the drugs at 37uC, in each case. After 16 h, the cells were lysed
in RIPA modified buffer and the viral proteins were analyzed by
Western blot with an anti-ASFV antibody. b-actin was detected as
a load control. Fold induction was determined by densitometry
and represented in the graphics below (mean 6S.D.) Cyto D,
Cytochalasin D; LY, LY294002; Rac1 Inh, Rac1 inhibitor.
*
Unspecific cellular protein detected by the antibody.
(TIF)
Figure S5 ASFV entry is not dependent on microtubule
system. Vero cells were treated with nocodazole at indicated
concentrations and infected with Ba71V (MOI 1) for 16 h. Viral
protein synthesis was analyzed by Western blot with an anti-ASFV
antibody. b-actin was detected as a load control.
* Unspecific
cellular protein detected by the antibody.
(TIF)
Figure S6 ASFV infection induces Akt phosphorylation
at early time post infection. Vero cells were asynchronously
infected (MOI 5) and solubilised in RIPA buffer at the indicated
times post infection. Equivalent amounts of protein were analyzed
by immunolotting and the phosphorylation level of Akt was
analyzed by using specific antibodies against phospho-Akt Ser473
and phospho-Akt Thr308. Levels of total Akt were measured as a
control.
(TIF)
Figure S7 Rac1 inhibitor effect on viral proteins
synthesis. Vero cells were treated with 200 mM Rac1 inhibitor
and infected with Ba71V (MOI 1) for 16 h. Samples were
solubilised in RIPA buffer and equivalent amounts of protein were
analyzed by Western blot with an anti-ASFV antibody. b-actin
was detected as a load control.
* Unspecific cellular protein
detected by the antibody.
(TIF)
Figure S8 Factors involved in macropinocytosis during
the infection in IPAM cells. IPAM cells were treated with
EIPA and LY (20 mM both) and infected with the isolate E70
during 42 h. Viral protein synthesis was analyzed by Western blot
with an anti-ASFV antibody. b-actin was detected as a load
control.
* Unspecific cellular protein detected by the antibody.
(TIF)
Table S1 Citotoxicity of pharmacological inhibitors.
Cells were treated with different pharmacological inhibitors for 3
or 18 hours in serum free medium. Cells were detached with
Trypsin-EDTA and stained with Trypan Blue. Percentage of dead
cells after treatment is calculated as a number of dead cells relative
to live cells. N/D, designated no data.
(TIF)
Video S1 In vivo Mock-infected Vero cells. Vero cells were
serum-starved for 24 h and medium without ASFV was added for
90 min at 4uC. Images were collected for 30 min with an Orca R2
digital camera on a widefield microscope with controlled
environmental chamber (temperature 37uC and 5% CO2
humidified atmosphere). Images were captured at a resolution of
134461024 pixels using a 206, 0.40 NA objective with a 1.66
magnification-changer.
(AVI)
Video S2 In vivo ruffle induction in Vero cells by ASFV.
Vero cells were serum-starved for 24 h and ASFV binding was
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were collected for 30 min with an Orca R2 digital camera on a
widefield microscope with controlled environmental chamber
(temperature 37uC and 5% CO2 humidified atmosphere). Images
were captured at a resolution of 134461024 pixels using a 206,
0.40 NA objective with a 1.66magnification-changer.
(AVI)
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